The economic impact of substandard and falsified antimalarial medications in Nigeria.
Sarah M BeargieColleen R HigginsDaniel R EvansSarah K LaingDaniel O ErimSachiko OzawaPublished in: PloS one (2019)
The results highlight the significant health and economic burden of poor quality antimalarials in Nigeria, and the impact of potential interventions to counter them. In order to reduce the burden of malaria and prevent antimalarials from developing resistance, policymakers and donors must understand the problem and implement interventions to reduce the impact of ineffective and harmful antimalarials.